STAT3 and hepatocellular carcinoma: The combined loss of STAT5/glucocorticoid receptor can cause approximately 60% HCC at 12 months, which is associated with enhanced TNF-α and ROS and the activation of c-Jun N-terminal kinase 1 and STAT3 (99).